Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 657 | $430,299,687 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Jun 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jun 2024 | Sale | 2 | 979.4 | 1,959 | D |
05 Jun 2024 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Jun 2024 | Sale | 1,138 | 980.16 | 1,115,422 | D |
29 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 28 May 2024 | Sale | 1,172 | 974.86 | 1,142,536 | D |
22 May 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 21 May 2024 | Sale | 1,865 | 994.9 | 1,855,488 | D |
17 May 2024 17:57 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 17 May 2024 | Sale | 143 | 980.07 | 140,150 | D |
17 May 2024 17:57 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 17 May 2024 | Sale | 22,687 | 979.22 | 22,215,564 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 120 | 989.14 | 118,697 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 373 | 988.36 | 368,658 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 182 | 987.38 | 179,703 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 442 | 986.4 | 435,989 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 647 | 985.62 | 637,696 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 53 | 984.02 | 52,153 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 727 | 983.88 | 715,281 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 303 | 982.29 | 297,634 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 2,283 | 981.52 | 2,240,810 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,223 | 980.72 | 1,199,421 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 504 | 979.87 | 493,854 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 4,865 | 978.44 | 4,760,111 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 9,851 | 977.42 | 9,628,564 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 5,225 | 975.6 | 5,097,510 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 6,885 | 976.56 | 6,723,616 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 4,778 | 974.47 | 4,656,018 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,865 | 973.43 | 1,815,447 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 784 | 972.5 | 762,440 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 846 | 970.36 | 820,925 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 406 | 971.28 | 394,340 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,930 | 969.14 | 1,870,440 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 3,387 | 968.43 | 3,280,072 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,428 | 967.45 | 1,381,519 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 782 | 966.29 | 755,639 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 111 | 965.69 | 107,192 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 379 | 978.18 | 370,730 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,886 | 976.52 | 4,771,277 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 1,227 | 977.38 | 1,199,245 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 9,242 | 975.48 | 9,015,386 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 7,611 | 974.51 | 7,416,996 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 2,653 | 973.8 | 2,583,491 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 790 | 972.22 | 768,054 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,922 | 971.56 | 4,782,018 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,669 | 970.26 | 4,530,144 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 9,501 | 969.39 | 9,210,174 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 907 | 967.4 | 877,432 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 3,213 | 968.44 | 3,111,598 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 299 | 988.76 | 295,639 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 228 | 987.46 | 225,141 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 103 | 986.57 | 101,617 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 281 | 985.72 | 276,987 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 305 | 984 | 300,120 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 250 | 983.91 | 245,978 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 235 | 982.66 | 230,925 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 1,081 | 981.5 | 1,061,002 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 295 | 980.64 | 289,289 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 7,864 | 979.05 | 7,699,249 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 14 May 2024 | Sale | 2,302 | 980.1 | 2,256,190 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 14 May 2024 | Sale | 22,698 | 979.16 | 22,224,974 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 1 | 913.21 | 913 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 1 | 912.29 | 912 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 4 | 911.39 | 3,646 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 6 | 910.47 | 5,463 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 4 | 909.49 | 3,638 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 4 | 906.26 | 3,625 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 2 | 907.54 | 1,815 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 2 | 905.5 | 1,811 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 1 | 904.8 | 905 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 1 | 903.35 | 903 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 1 | 902.66 | 903 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 4 | 901.41 | 3,606 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 5 | 900.45 | 4,502 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 17 | 898.51 | 15,275 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 7 | 899.37 | 6,296 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 9 | 897.68 | 8,079 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 3 | 896.59 | 2,690 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 2 | 895.38 | 1,791 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 5 | 893.16 | 4,466 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 9 | 892.5 | 8,032 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 7 | 891.52 | 6,241 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 2 | 890.75 | 1,782 | D |
03 May 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 May 2024 | Sale | 3 | 889.5 | 2,668 | D |
03 May 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 May 2024 | Sale | 250 | 889.41 | 222,352 | D |
01 May 2024 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
03 Apr 2024 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Apr 2024 | Sale | 250 | 964.73 | 241,182 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 13 | 965.35 | 12,550 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 16 | 964.45 | 15,431 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 20 | 963.6 | 19,272 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 9 | 962.42 | 8,662 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 14 | 961.59 | 13,462 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 15 | 960.53 | 14,408 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 9 | 959.47 | 8,635 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 2 | 957.78 | 1,916 | D |
03 Apr 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Apr 2024 | Sale | 2 | 958.86 | 1,918 | D |
06 Sep 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Sep 2023 | Sale | 250 | 834.55 | 208,638 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 2,534 | 844.27 | 2,139,380 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 759 | 843.31 | 640,072 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 617 | 842.66 | 519,921 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 363 | 841.15 | 305,337 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 46 | 840.74 | 38,674 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 148 | 839.28 | 124,213 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 667 | 838.37 | 559,193 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 300 | 837.53 | 251,259 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 625 | 836.32 | 522,700 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)